In April, McDermott was pleased to once again host our annual European Health & Life Sciences Symposium in Paris. Welcoming a crowd of more than 300 innovators, investors, business leaders and advisers from across the...more
5/13/2025
/ Acquisitions ,
Biotechnology ,
EU ,
Financing ,
Investment ,
Investors ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Private Equity ,
Venture Capital
Welcome to this edition of Credit Conditions, a quarterly publication from McDermott Will & Emery that analyzes recent debt market trends.
The fourth quarter of 2024 marked a pivotal moment in the debt market, as the...more
3/3/2025
/ Acquisitions ,
Capital Markets ,
Capital Raising ,
Federal Reserve ,
Financial Markets ,
Financial Services Industry ,
Interest Rates ,
Investment ,
Investment Funds ,
Mergers ,
Private Equity
The Private Markets Update highlights key developments emerging from private markets across Europe, the UK and the United States, exploring the cross-border issues that matter to investors and sponsors in alternative assets. ...more
10/16/2024
/ Acquisitions ,
Artificial Intelligence ,
Capital Markets ,
Cross-Border ,
EU ,
EUMR ,
Financial Conduct Authority (FCA) ,
Greenwashing ,
Healthcare ,
Investment ,
Investment Management ,
Investors ,
Life Sciences ,
Mergers ,
Private Equity ,
Regulatory Agenda ,
Regulatory Requirements ,
UK ,
United States
200+ leading individuals in healthcare, life sciences and private equity gathered at the Shangri-La Hotel in Paris for the European Health & Life Sciences Symposium 2023 to enjoy a day packed with fireside chats, in-depth...more
11/28/2023
/ Artificial Intelligence ,
Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Information Technology ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
We can't wait to see you in Paris at our second annual symposium. You'll meet with senior executives in the health, life sciences and private equity industries to identify new investment opportunities and position your...more
10/19/2023
/ Artificial Intelligence ,
Events ,
Financing ,
Health Care Providers ,
Health Information Technologies ,
Healthcare Facilities ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
240+ leading individuals in healthcare, life sciences and private equity gathered at The Langham Hotel in central London for HPE Europe 2023 for a day packed with fireside chats, in-depth plenary sessions and an abundance of...more
HPE Europe is back!
Join the biggest names in healthcare, life sciences and private equity for an unforgettable day of thought-provoking discussions, cutting-edge insights and valuable networking opportunities at the...more
8/16/2023
/ Artificial Intelligence ,
Digital Health ,
Events ,
Health Care Providers ,
Health Information Technologies ,
Health Technology ,
Healthcare Facilities ,
Investment Banks ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
Welcome to the inaugural Private Markets Update, which highlights developments in the European private markets, covering the issues that matter to investors in alternative assets. Touching on themes as diverse as predictions...more
5/31/2023
/ Acquisitions ,
Capital Markets ,
Cross-Border ,
EU ,
FinTech ,
Germany ,
Investment ,
Investors ,
Mergers ,
National Security ,
OECD ,
Pillar 2 ,
Private Equity ,
Private Equity Funds ,
Restructuring ,
UK
Key Trends & Opportunities in Life Sciences and Healthcare Investing -
The current macroeconomic environment is creating challenges for healthcare and life sciences businesses, which have been impacted hard by wage...more
12/9/2022
/ Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
After an insightful conference in Cannes, our partners have compiled some of the key takeaways from IPEM 2022.
As well as exploring the private equity landscape in the UK, Germany, France and Italy, we also explore the...more
10/25/2022
/ Acquisitions ,
Debt ,
Economic Growth ,
Environmental Social & Governance (ESG) ,
EU ,
France ,
Funding ,
Germany ,
Healthcare ,
Investment ,
Investors ,
Italy ,
Mergers ,
Private Equity ,
Publicly-Traded Companies ,
Small and Medium-Sized Enterprises (SMEs) ,
UK ,
Venture Capital
During this session, Aymen Mahmoud, partner and co-head of the London Finance, Restructuring and Special Situations Group, led a discussion that explored the metrics that can be used to differentiate between short- and...more
The challenges facing traditional banks over the last 12 months have proved to be golden opportunities for private lending. Aymen Mahmoud has more on private equity and private credit. ...more
This year, recognising that as we are still unable to meet in person, our HPE Europe EVENT will be going ahead with two exclusive, virtual extended lunch time sessions.
We will be joined by investors including key players...more
6/9/2021
/ Acquisitions ,
Business Valuations ,
Coronavirus/COVID-19 ,
Financing ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Investment Opportunities ,
Investors ,
Lenders ,
Leveraged Loans ,
Life Sciences ,
Mergers ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Risk Management ,
Webinars
Last year presented a great many challenges, and much like 2008–2009, the impact was felt on a global basis. The last quarter of 2020 appeared to start with a sense of renewed optimism, with the end of pandemic-driven issues...more
1/28/2021
/ Biden Administration ,
Coronavirus/COVID-19 ,
Debt Restructuring ,
Equity Markets ,
EU ,
Global Economy ,
Global Market ,
New Legislation ,
Private Equity ,
UK ,
United States
During these unprecedented times, many funds seek opportunities to deploy capital, with a particular focus on the “special situations” space. A certain amount of heightened risk (or risk perception) in this economic climate...more